Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease
Introduction: Data on longitudinal trajectory of kidney function decline and fluctuation in albuminuria leading to end-stage kidney disease (ESKD) is sparse in patients with type 2 diabetes. Methods: Using data from an observational study of patients with type 2 diabetes and biopsy-confirmed diabeti...
| Published in: | Kidney International Reports |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-02-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024923015802 |
| _version_ | 1849569434558005248 |
|---|---|
| author | Masayuki Yamanouchi Naoki Sawa Tadashi Toyama Miho Shimizu Megumi Oshima Yusuke Yoshimura Hisashi Sugimoto Shigekazu Kurihara Yuki Oba Daisuke Ikuma Hiroki Mizuno Akinari Sekine Tatsuya Suwabe Junichi Hoshino Yoshifumi Ubara Shigeko Hara Kengo Furuichi Takashi Wada |
| author_facet | Masayuki Yamanouchi Naoki Sawa Tadashi Toyama Miho Shimizu Megumi Oshima Yusuke Yoshimura Hisashi Sugimoto Shigekazu Kurihara Yuki Oba Daisuke Ikuma Hiroki Mizuno Akinari Sekine Tatsuya Suwabe Junichi Hoshino Yoshifumi Ubara Shigeko Hara Kengo Furuichi Takashi Wada |
| author_sort | Masayuki Yamanouchi |
| collection | DOAJ |
| container_title | Kidney International Reports |
| description | Introduction: Data on longitudinal trajectory of kidney function decline and fluctuation in albuminuria leading to end-stage kidney disease (ESKD) is sparse in patients with type 2 diabetes. Methods: Using data from an observational study of patients with type 2 diabetes and biopsy-confirmed diabetic kidney disease (DKD), generalized additive mixed models (GAMMs) were performed to quantify patterns of longitudinal trajectory of estimated glomerular filtration rate (eGFR) decline to ESKD associated with repeated measures of urine albumin-to-creatinine ratio (ACR). Results: Over a median follow-up period of 3.3 years, 155 of 319 patients progressed to ESKD. Among these patients, 91.6% exhibited a curvilinear pattern in their eGFR trajectory. The median coefficient of variation for ACR, representing the variability in ACR measurements, was 48.9 (interquartile range: 36.9, 68.2). The median compound annual growth rate (CAGR) for ACR, reflecting the variation in ACR progression over time, was 43.6% (interquartile range: 0.0, 102.5); and 84.5% of patients developed nephrotic-range albuminuria, with a majority remaining nephrotic and subsequently progressing to ESKD. There was a positive association between the instantaneous speed of eGFR decline and ACR. Conclusion: The observed curvilinear pattern in eGFR trajectory, high variability in ACR progression over time, and positive correlation between the speed of eGFR decline and ACR highlight the complex dynamics of disease progression and emphasize close monitoring of ACR fluctuation over time in patients with DKD. |
| format | Article |
| id | doaj-art-7db4e2545cc3469bbfe8ada03fba7457 |
| institution | Directory of Open Access Journals |
| issn | 2468-0249 |
| language | English |
| publishDate | 2024-02-01 |
| publisher | Elsevier |
| record_format | Article |
| spelling | doaj-art-7db4e2545cc3469bbfe8ada03fba74572025-08-20T02:31:47ZengElsevierKidney International Reports2468-02492024-02-019232333310.1016/j.ekir.2023.11.004Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney DiseaseMasayuki Yamanouchi0Naoki Sawa1Tadashi Toyama2Miho Shimizu3Megumi Oshima4Yusuke Yoshimura5Hisashi Sugimoto6Shigekazu Kurihara7Yuki Oba8Daisuke Ikuma9Hiroki Mizuno10Akinari Sekine11Tatsuya Suwabe12Junichi Hoshino13Yoshifumi Ubara14Shigeko Hara15Kengo Furuichi16Takashi Wada17Nephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan; Okinaka Memorial Institute for Medical Research, Tokyo, Japan; Department of Nephrology and Rheumatology, Kanazawa University, Ishikawa, Japan; Department of Nephrology, Kanazawa Medical University School of Medicine, Ishikawa, Japan; Correspondence: Masayuki Yamanouchi, Nephrology Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.Nephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanDepartment of Nephrology and Rheumatology, Kanazawa University, Ishikawa, JapanDepartment of Nephrology and Rheumatology, Kanazawa University, Ishikawa, JapanDepartment of Nephrology and Rheumatology, Kanazawa University, Ishikawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital, Tokyo, JapanNephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanDepartment of Medicine, Kidney Center, Tokyo Women’s Medical University, Tokyo, JapanNephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanHara Press Center Clinic, Tokyo, JapanDepartment of Nephrology, Kanazawa Medical University School of Medicine, Ishikawa, JapanDepartment of Nephrology and Rheumatology, Kanazawa University, Ishikawa, Japan; Takashi Wada, Kanazawa University, 13-1 Takaramachi, Kanazawa 920-0934, Japan.Introduction: Data on longitudinal trajectory of kidney function decline and fluctuation in albuminuria leading to end-stage kidney disease (ESKD) is sparse in patients with type 2 diabetes. Methods: Using data from an observational study of patients with type 2 diabetes and biopsy-confirmed diabetic kidney disease (DKD), generalized additive mixed models (GAMMs) were performed to quantify patterns of longitudinal trajectory of estimated glomerular filtration rate (eGFR) decline to ESKD associated with repeated measures of urine albumin-to-creatinine ratio (ACR). Results: Over a median follow-up period of 3.3 years, 155 of 319 patients progressed to ESKD. Among these patients, 91.6% exhibited a curvilinear pattern in their eGFR trajectory. The median coefficient of variation for ACR, representing the variability in ACR measurements, was 48.9 (interquartile range: 36.9, 68.2). The median compound annual growth rate (CAGR) for ACR, reflecting the variation in ACR progression over time, was 43.6% (interquartile range: 0.0, 102.5); and 84.5% of patients developed nephrotic-range albuminuria, with a majority remaining nephrotic and subsequently progressing to ESKD. There was a positive association between the instantaneous speed of eGFR decline and ACR. Conclusion: The observed curvilinear pattern in eGFR trajectory, high variability in ACR progression over time, and positive correlation between the speed of eGFR decline and ACR highlight the complex dynamics of disease progression and emphasize close monitoring of ACR fluctuation over time in patients with DKD.http://www.sciencedirect.com/science/article/pii/S2468024923015802diabetic kidney diseaseglomerular filtration ratealbuminuriaend-stage kidney diseasetrajectory of eGFRfluctuation in albuminuria |
| spellingShingle | Masayuki Yamanouchi Naoki Sawa Tadashi Toyama Miho Shimizu Megumi Oshima Yusuke Yoshimura Hisashi Sugimoto Shigekazu Kurihara Yuki Oba Daisuke Ikuma Hiroki Mizuno Akinari Sekine Tatsuya Suwabe Junichi Hoshino Yoshifumi Ubara Shigeko Hara Kengo Furuichi Takashi Wada Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease diabetic kidney disease glomerular filtration rate albuminuria end-stage kidney disease trajectory of eGFR fluctuation in albuminuria |
| title | Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease |
| title_full | Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease |
| title_fullStr | Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease |
| title_full_unstemmed | Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease |
| title_short | Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease |
| title_sort | trajectory of gfr decline and fluctuation in albuminuria leading to end stage kidney disease in patients with biopsy confirmed diabetic kidney disease |
| topic | diabetic kidney disease glomerular filtration rate albuminuria end-stage kidney disease trajectory of eGFR fluctuation in albuminuria |
| url | http://www.sciencedirect.com/science/article/pii/S2468024923015802 |
| work_keys_str_mv | AT masayukiyamanouchi trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT naokisawa trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT tadashitoyama trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT mihoshimizu trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT megumioshima trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT yusukeyoshimura trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT hisashisugimoto trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT shigekazukurihara trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT yukioba trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT daisukeikuma trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT hirokimizuno trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT akinarisekine trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT tatsuyasuwabe trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT junichihoshino trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT yoshifumiubara trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT shigekohara trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT kengofuruichi trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease AT takashiwada trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease |
